<DOC>
	<DOCNO>NCT00807885</DOCNO>
	<brief_summary>The purpose evaluate ease use technical challenge encounter subcutaneous infusion Lactated Ringer 's ( LR ) solution , precede recombinant human hyaluronidase ( hylenex ) , utilize commonly use angiocatheter gauge button delivery system . The safety tolerability hylenex-augmented SC infusion LR delivery system also evaluate .</brief_summary>
	<brief_title>Study Techniques Subcutaneous Administration Fluids Enabled Human Recombinant Hyaluronidase</brief_title>
	<detailed_description />
	<mesh_term>Dehydration</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>male female , age 18 60 year intact normal skin without potentially obscure feature anterior thigh area intend infusion agree fluid intake 12 hour prior start study infusion vital sign within normal range , outside normal range , deem clinically significant metabolic panel , hematology , virology standard 10test urine dipstick test within normal range , outside normal range , deem clinically significant female childbearing potential , negative serum pregnancy test negative urine drug screen write informed consent participation low extremity edema low extremity pathology could interfere study outcome history cardiovascular disease rale lung auscultation know allergy hyaluronidase ingredient formulation hylenex pregnancy breastfeed child exposure experimental drug within 30 day prior study participation previous participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>dehydration</keyword>
	<keyword>fluid therapy</keyword>
	<keyword>hyaluronoglucosaminidase</keyword>
	<keyword>hyaluronidase</keyword>
	<keyword>hypodermoclysis</keyword>
	<keyword>clysis</keyword>
	<keyword>subcutaneous hydration</keyword>
	<keyword>subcutaneous rehydration</keyword>
	<keyword>hyaluronan</keyword>
	<keyword>rHuPH20</keyword>
</DOC>